Metabolic and Endocrine Newsletters

Welcome to the MedscapeLIVE! Metabolic and Endocrine monthly newsletter. Each month we will interview the top NP's and PA's in their fields to provide you with updates and insights.

Metabolic and Endocrine

—

October

Medscape Metabolic and Endocrine October E-News MEDS Fall 2023 Is Upon Us!

Welcome to the October meeting issue of Metabolic and Endocrine eNews! This month we talk to some of the faculty for the upcoming Metabolic & Endocrine Disease Summit Fall (MEDS), which is being held in-person from October 12-14, 2023 in Orlando, Florida. MEDS Fall will bring you the latest cutting-edge knowledge and clinical breakthroughs in metabolic and endocrine diseases—diabetes, thyroid and adrenal disorders, obesity, and everything in between, to make a lasting difference in your patients’ lives!

Metabolic and Endocrine

—

September

Insights from Rick Pope

In this issue, Rick shares valuable pearls from his upcoming MEDS Fall presentations, and we also discussed several critical components of MEDS care specific to osteoporosis and rheumatology treatment options. Don’t miss the Rapid Fire! segment where Rick weighs in on some interesting topics as well.

Metabolic and Endocrine

—

August

5 Minutes With… MEDS 2023 Faculty (Part 1)

Welcome to the August issue of Metabolic and Endocrine eNews! This month we present a “5 Minutes With” segment that questions some of our foremost thought leaders. These key opinion leaders also serve as faculty for the upcoming Metabolic & Endocrine Disease Summit Fall (MEDS).

Metabolic and Endocrine

—

July

5 Minutes With: Donna Jornsay, MS, BSN, RN, CPNP, CDCES, BC-ADM

Welcome back to MEDS eNews! This month we spend some time with Metabolic and Endocrine Disease Summit Fall faculty Donna Jornsay, a nurse practitioner and diabetes educator who has lived well with T1DM for 54 years and is going strong! She discusses the role and importance of physical activity in maintaining glucose control in both T1D& T2D, whether CGM and/or frequent blood glucose monitoring more clinically significant than A1C alone, recent studies that have shown increased incidence and prevalence of youth-onset T2DM, and regarding diabetes and pregnancy, is there an ideal screening criteria that should be the standard? What about a standard for glucose targets? Following the interview is our Rapid Fire segment with Donna as well!

Metabolic and Endocrine

—

June

Most Interesting Cases—from MEDS 2023 Faculty

This month I tapped into some of our upcoming virtual Metabolic & Endocrine Disease Summit 2023 (MEDS) faculty to find out about their most recent interesting cases. In this field, some cases more than others can really be a challenge to address for various reasons—here are three that these faculty share for your benefit.In last month’s issue, thought leaders weighed in on the most challenging thing(s) to treat, the team approach to multifaceted care, and the challenge to keep current on new advances, research and literature—and what they do to stay up to date across multiple clinical spectrums.

Metabolic and Endocrine

—

May

5 Minutes With… MEDS 2023 Faculty Part 2

This month we present Part 2 of the special segment “5 Minutes With” that questions some of our foremost thought leaders. In Part 2 here, we discuss the most challenging thing(s) to treat, since the care of our patients is often multifaceted, how they and their team approach multifaceted care to consolidate efforts and provide the most efficient treatment, and how, with care that is multidisciplinary, it can be a challenge to keep current on new advances, research and literature—and what they do to stay up to date across multiple clinical spectrums. Read on for candid insights from these faculty.

Metabolic and Endocrine

—

April

5 Minutes With… MEDS 2023 Faculty

This month we present Part 1 of a special segment called “5 Minutes With” that questions some of our foremost thought leaders. These key opinion leaders also serve as faculty for the upcoming MEDS Summer 2023, which is being held virtually from July 13 through 15. In the words of one faculty, David Doriguzzi, “MEDS 2023 is going to cover a wide variety of important endocrine topics that should give both primary care and endocrine specialty providers an amazing readiness to treat common and not-so-common disorders.”‍

Metabolic and Endocrine

—

March

Obesity, Hypothyroidism, and the New “Game-Changer” Medications for Weight Loss & T2DM: Christine Kessler Breaks It Down

Welcome back to MEDS eNews! This month we spend some time with Metabolic and Endocrine Disease Summit Fall faculty Christine Kessler, a nurse practitioner specializing in general endocrinology, obesity, and metabolic medicine and founder of Metabolic Medicine Associates in rural Virginia. She shares her excitement with us on access to hormone-based weight loss therapies, Incretin therapies, single and combination hormones for obesity and T2DM, as well as takeaways from her recent talks on Obesity Care and Management in the Cardio-Metabolic Patient and Hypothyroidism Management Tips. Following the interview is our Rapid Fire segment!

Metabolic and Endocrine

—

February

5 Minutes with Davida Kruger, MSN, APN-C, BC-ADM

Welcome back to MEDS eNews. This month we spend some time with Metabolic and Endocrine Disease Summit Fall faculty Davida Kruger, who is a Nurse Practitioner at Henry Ford Health System, Division of Endocrinology, Diabetes, Bone Disease, and Adjunct Clinical Faculty, Graduate School of Nursing, Michigan State University in Detroit, Michigan. Davida has spent her career as a certified nurse practitioner in diabetes for more than 35 years. Her role includes both clinical practice and research, and she is board-certified in both primary care and advanced diabetes management. She is also a co-investigator on numerous studies of diabetes interventions and care, including the National Institutes of Health-funded multicenter EDIC and ACCORD trials.

Metabolic and Endocrine

—

January

Rick Pope Weighs In!

Happy New Year! Welcome back to MEDS eNews. For this first month issue of 2023, I got a chance to speak with Rick Pope MPAS, PA-C, DFAAPA, CPAAPA. I’ve wanted to catch up with Rick since his presentations at the recent MEDS Summit because they were so well received. So I asked him here about these topics and then some other critical aspects of MEDS care. Rick is an author and Clinical Professor at the University of Bridgeport PA Institute, Sacred Heart University PA Program, Rheumatology PA (emeritus) Department of Rheumatology, Danbury Hospital, in Connecticut, and Founder and Past President of the Society of PAs in Rheumatology.

Thank you! Your submission has been received!

Oops! Something went wrong while submitting the form.

Loading ...